BMC Infectious Diseases

, 18:140 | Cite as

Spoligotyping based genetic diversity of Mycobacterium tuberculosis in Ethiopia: a systematic review

Open Access
Research article
Part of the following topical collections:
  1. Tuberculosis and other mycobacterial diseases

Abstract

Background

Understanding the types of strains and lineages of Mycobacterium tuberculosis (M. tuberculosis) circulating in a country is of paramount importance for tuberculosis (TB) control program of that country. The main aim of this study was to review and compile the results of studies conducted on strains and lineages of M. tuberculosis in Ethiopia.

Methods

A systematic search and review of articles published on M. tuberculosis strains and lineages in Ethiopia were made. PubMed and Google Scholar databases were considered for the search while the keywords used were M. tuberculosis, molecular epidemiology, molecular typing spoligotyping and Ethiopia.

Result

Twenty-one studies were considered in this review and a total of 3071 M. tuberculosis isolates and 3067 strains were included. These studies used spoligotyping and identified five lineages including Indo-Ocean, East Asian/Beijing, East African-Indian, Euro-American and Ethiopian in a proportion of 7.1%, 0.2%, 23.0%, 64.8%, and 4.1%, respectively. Thus, Euro-American was the most frequently (64.8%) occurring Lineage while East Asian was the least (0.2%) frequently occurring Lineage in the country. Surprisingly, the Ethiopian Lineage seemed to be localized to northeastern Ethiopia. In addition, the top five clades identified by this review were T, CAS, H, Manu and Ethiopian comprising of 48.0%, 23.0%, 11.0%, 6.0% and 4.1% of the strains, respectively. Furthermore, predominant shared types (spoligotype patterns) identified were SIT149, SIT53, SIT25, SIT37, and SIT21, each consisting of 420, 343, 266, 162 and 102 isolates, respectively, while, on the other hand, 15% of the strains were orphan.

Conclusion

According to the summary of the results of this review, diversified strains and lineages of M. tuberculosis were found in Ethiopia, and the frequencies of occurrence of these strains and lineages were variable in different regions of the country. This systematic review is registered in the PRISMA with the registration number of 42017059263.

Keywords

Mycobacterium tuberculosis Molecular epidemiology Genotyping Diversity Ethiopia 

Abbreviations

CAS

Central Asian

CRISPR

Clustered regularly interspaced short palindromic repeats

DR

Direct repeat

GIS

Geographic information system

HBCs

High burden countries

HIV

Human immunodeficiency virus

LAM

Latin-American

MDR

Multi-drug resistant

MIRU-VNTRs

Mycobacterial interspersed repetitive units-variable tandem repeats of DNA tandem repeats

MTBC

Mycobacterium tuberculosis complex

RFLP

Restriction fragment length polymorphism

TB

Tuberculosis

WHO

World Health Organization

XDR

Extensive drug resistant

Background

M. tuberculosis, the causative agent of TB is still the major health problem especially in low-income countries pausing significant morbidity and mortality [1, 2]. According to World Health Organization (WHO) report of 2016, globally there were an estimated 10.4 million new TB cases and 1.4 million TB deaths in the year 2015. Similarly, 11% of people who developed TB were HIV positive and 31% of TB cases in African Region was estimated to live with HIV. The report also indicated that the African Region had 26% of the world’s TB cases, but carries the most severe burden relative to population [3].

Ethiopia is also among 30 high burden countries (HBCs) and TB is one the leading causes of mortality amongst the communicable diseases in the country. In 2015, the incidence of all forms of TB was 192 per 100,000 population. Moreover, Ethiopia is also one of the high TB/HIV and multi-drug resistant TB (MDR-TB) burden countries [3]. WHO estimated that the incidence of HIV/TB co-infection was 16 per 100,000 population [3]. The emergence of drug-resistant (DR), multidrug-resistant (MDR) and extreme drug resistant (XDR) strains are the greatest threat to the TB control program [4]. In Ethiopia, based on the latest national anti-TB drug susceptibility surveillance report, a significantly higher proportion of MDR TB cases were reported among previously treated cases (17.8%) compared to newly diagnosed TB cases (2.3%) [5].

It is highlighted that, in addition to the problem associated with HIV co-infection and emergence of drug resistance, the continued TB transmission is highly linked to the missed cases or undiagnosed TB cases as a result of inefficient case detection and or poor diagnosis capacity [6], ineffective vaccine [7] and prolonged anti-TB treatment [4]. On the other hand, it is becoming clear that the outcome of TB infection is strangely diverse, ranging from active pulmonary TB to latent infection and disseminated extra-pulmonary TB [8]. This diverse TB infection outcome is attributed to the dynamics of host-pathogen-environment interaction. M. tuberculosis is transmitted by inhalation and once the bacterium gets access to the lung it is phagocytosed by the predominant phagocytic cells, the resident alveolar macrophages. Phagocytosis of M. tuberculosis by macrophages triggers the initiation and production immune response, that ultimately help in the containment of infection through granuloma formation [9, 10].

About half of the exposed individuals to M. tuberculosis will be infected; but only 1 in 10 of those infected develops active pulmonary diseases, suggesting that there are differences in the susceptibility or resistance to diseases development among individuals [11]. Certain clinical conditions including immunodeficiency, the presence of co-infections, malnutrition, individuals with compromised lungs, and other chronic illnesses may increase susceptibility to TB diseases compared to healthy individuals [12, 13]. Moreover, the outcome of TB infection depends on the complex interaction between the host, the agent, and the environment [14].

Genomics of M. tuberculosis

Human TB is predominantly caused by M. tuberculosis which is a member of M. tuberculosis complex (MTBC) know by identical 16S rRNA sequences and 99.9% similarity at nucleotide level [15]. Briefly, the members of MTBC includes M. tuberculosis, M. africanum, M. canneti, M. microti, and M. bovis. The members of the complex are also known by slow-growing nature with doubling time ranging from 12 to 24 h which of course affected by pathogen character and environmental factors. Despite the genotypic similarity amongst the members of MTBC, they differ greatly in terms of their ability to cause disease, host preferences, and phenotypic characteristics [15].

Based on complete genome analysis, the M. tuberculosis found to have close to 4.4Mbp genome and consists of 65.5% GC. Deciphering the whole genome of M. tuberculosis has provided new concepts on the understanding of the properties and history of the bacilli [16]. Compared to other bacteria, M. tuberculosis is also known by relatively highly clonal, no horizontal transfer, and low mutation and recombination rates [16].

The tendency to transmit and cause disease varies based on its phylogeny which consists of four major lineages (L-1 Indo Oceanic, L-2 East-Asian, L-3 East-African-Indian, L-4 Euro-American and more recently L-7 Ethiopian) [9, 17, 18]. For instance, the Beijing family has got a great deal of attention compared to other families of M. tuberculosis because some study demonstrated its association with drug resistance [19] and some experimental models have demonstrated its hypervirulence [20]. On the other hand, other human-associated M. tuberculosis lineages have been given less attention partly because of the lack of standardized and phylogenetically robust classification system and associated nomenclature [18].

Molecular typing of M. tuberculosis is applied to study the type of strain circulating, distinguishing relapse strain versus re-infection, or detecting laboratory cross-contamination of M. tuberculosis strain [18] and overall evaluating the TB control programmes. With this aim, the currently available M. tuberculosis genotyping tools are not equally appropriate. For instance, restriction fragment length polymorphism (RFLP) analysis which bases on the monitoring the number of insertion sequence IS6110 in the chromosome which varies among different strains [21] and mycobacterial interspersed repetitive units-variable tandem repeats of DNA tandem repeats (MIRU-VNTRs) which rely on measuring repetitive DNA elements [22] are tools known by having relatively highly discriminatory power compared to spoligotyping that detects polymorphisms present in a direct repeat (DR) locus [23]. Although spoligotyping is also prone to homoplasy as individual spacers can be deleted independently in phylogenetically unrelated strains, it has several large international databases that compiled thousands of clinical isolates from many countries [18, 24].

Most recently, large sequence polymorphisms (LSPs) and single nucleotide polymorphisms (SNPs) have been introduced primarily to study the phylogenetic and strain classification of M. tuberculosis [24]. Above all, whole genome sequencing (WGS) is hoped to be the next gold standard for molecular epidemiology of MTBC because it has demonstrated a much higher discriminatory power than the standard genotyping tools despite its high cost and requirement of bioinformatics capacity to analyze the data [18].

In Ethiopia, there are several studies conducted to understand the transmission dynamics and types of stains involved in causing TB [17, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52]. However, the majority of these reports use different methodologies and as a result, it is difficult to understand the clear picture of transmission dynamics and strains involved in causing TB in the country. And also a systematic review of current genotypes has not been performed before. Hence, in order to analyze the circulating M. tuberculosis strains from Ethiopia, we reviewed studies that determined the genetic diversity of M. tuberculosis strains in patients with either pulmonary TB or extra-pulmonary TB from different Regions of Ethiopia.

Methods

PubMed and Google Scholar Databases were used to identify studies with no limitation to the language and year of publication. The last search was conducted on March 27, 2017, using terms: Mycobacterium tuberculosis AND molecular epidemiology OR molecular typing OR spoligotyping AND Ethiopia. The analysis was performed based on the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) Statement [53].

The screening of articles was performed based on their relevance of the title, abstract and manuscript review. In order to minimize the risk of bias, the data was extracted from the selected studies and inserted into a data sheet by one reviewer and across studies, genotype frequency comparison was performed only when the same genotyping method was used.

This review was conducted on studies published on genetic diversity of M. tuberculosis isolates from different regions of the Ethiopian population. Ethiopia is a country situated between 80N and 38°E coordinates in the Horn of Africa. The country shares border with Kenya to the south, Eritrea to the north and northeast, Djibouti and Somalia to the east and Sudan and South Sudan to the west. The Country is one of the most populous landlocked country in the world, as well as the second most populous country in Africa next to Nigeria with a population close to 100 million people. The country is also known by a home diverse nation and nationalities with more than 80 ethnolinguistic groups. The three largest nations are Oromo, Amhara, and Somali (https://en.wikipedia.org/wiki/Ethiopia).

The following major information was extracted from each study: 1) type of study participants (including pulmonary or extrapulmonary TB from Ethiopian regions, whether the participants were primary TB patients or re-treatment patients); 2) characteristics of genetic diversity (including region, year, number of strains and population); 3) type of intervention (type of genotyping method used: spoligotyping); 4) type of outcome measures (clustering rate, shared types, lineages, and frequency of novel genotypes).

Three different analysis was performed. First, we obtained the frequency of shared types found in each study and compared it to Ethiopian regions. Clustering rates were also determined (clustered shared type, representing two or more identical shared type, representing two or more identical shared type found within study/region; unique, representing a single shared type found within study/region). Moreover, a multi-marker database for M. tuberculosis (SITVITWEB) and TBinsight were also used to supplement for those studies which do not include spoligotype description and frequency.

Result

We performed a qualitative synthesis of the results for the genotyping and their outcome measures because the studies we found varied significantly based on the study design used, types of study participants and methods used for genotyping. As a result, the scope of this review primarily focuses on the results of the studies, their applicability and their limitations rather than meta-analysis. The main inclusion criteria used were entitled strains from Ethiopia with genetic diversity analysis. We selected studies published in English from Ethiopia without any time limitations. A total of 21 studies were selected for the purpose of this review (Fig. 1). In these studies, a total of 11,365 TB patients were involved and 3067 M. tuberculosis strains were obtained.
Fig. 1

PRISMA flow diagram of study selection and literature search. A total of 21 studies involving 3067 clinical strains were identified for inclusion in the review. A total of 133 citations were identified from PubMed and Google Scholar databases. Of these, 30 studies were selected which used genotyping analysis by Spoligotyping after reviewing the title and abstracts. Additional screening was conducted in the full text and journal quality was considered and additionally, 9 studies were excluded because of repeated publication and data were not available

In understanding strain diversity of M. tuberculosis, whole genome sequencing is believed to offer many advantages compared to the classical methods like RFLP, spoligotyping and MIRU-VNTR studies [18]. Nevertheless, whole genome sequencing remains relatively costly and requires advanced capacity ranging from wet lab to big data analysis [18]. In line with this, there were only a few studies reported genome sequencing of M. tuberculosis and even MIRU-VNTR techniques in Ethiopia [17, 41, 50]. Recently, Firdessa et al. sequenced four M. tuberculosis isolates out of 36 isolates with unusual pattern (missing spacers 4–24) using (Illumina Inc., San Diego, CA, USA) and found to be members of L-7 localized between ancient lineage 1 and modern lineages 2, 3 and 4 of M. tuberculosis phylogeny [17]. Similarly, 30 L-7 strains from the Northern part of Ethiopia were sequenced and identified over 800 mutations specific to the lineage with a total of 22,346 bp deletions [50].

Most recently, Comas et al. sequenced 66 strains [41] from the previously spoligotyped M. tuberculosis collections [17] and identified representatives of five of the eight L4 sub-lineages in Ethiopian data set and assigned three of the five within L3 (provisionally named as L3.ETH1, L3.ETH2 and L3.ETH) and four of eight within L1 [41]. Likewise, strains like SIT 343, SIT 910, and SIT 1729 which are found to be assigned under new Ethiopian L-7 [17, 46] were being reported as either M. africanum (the West African Lineage) or Indo Oceanic or unique or new or unknown strains [30, 31, 34, 37, 39, 44, 47, 51, 52, 54].

On the other hand, the highest number of strains which were not registered in the global database (new/orphan) were reported from the study at Oromia (45.8%) [36]. A high clustering rate has been reported from Ethiopia which ranges from 31.2% [49] to 85.9% [32]. Consistently, two studies on drug-resistant strains from Addis Ababa city administration also reported very high clustering rates 80.4% [28] and 85.9% [32].

Spoligotyping results of M. tuberculosis strains from Ethiopia

There were only very few studies reported using methods like RFLP-IS6110 (2 studies), WGS (3 studies) and MIRU-VNTR (3 studies). As a result, for the purpose of this review, we only included studies that reported based on the spoligotyping techniques (Table 1). A total of 21 studies have used spoligotyping for genetic diversity analysis (n = 3071). In the Additional file 1, a description of the M. tuberculosis shared types (n = 2596) in Ethiopia so far from nine regional states and two federal cities of Ethiopia were listed. Regarding the diversity and proportions of shared strains reported from The Regions, the highest proportion of strains were reported from Amhara region (AM) (36.0%) followed by Oromoia (OR) (28.5%), Addis Ababa (AA) city administration (21.0%), and South Nation and Nationalities Peoples Region (SNNPR) (10.0%). There were only four strains from Tigray (TG), one strain each from Dire Dawa (DD) and Harari (HR) regions reported in the shared spoligotyping pattern. Unfortunately, there were no reported shared strains from Gambella region. The largest shared spoligotyping pattern was from Amhara (AM) region followed by Oromia (OR) and Addis Ababa (AA) regions (Figs. 2 and 3). On the other hand, the total of 15.0% of the reported strains was found to be orphan.
Table 1

Description of reports on the strains of M. tuberculosis isolated from Ethiopia included in this review

Author

Study Regiona

Type of Patientsb

No. isolates

Typing methodc

No. strains

Clustering rate (%)

Shared rated (%)

Predominant strains

Lineage/Clade

Agonafir et al., 2010 [28]

AA

MDR-TB

107

Spoligotyping

81

80.43

82.61

SIT149

T, CAS

Deribew et al., 2012 [29]

OR

PTB

17

Spoligotyping

17

64.71

64.71

SIT777

T, H, CAS

Mihret et al., 2012 [30]

AA

PTB

192

Spoligotyping

192

82.81

88.02

SIT149

T, CAS, H

Ameni et al., 2013 [31]

OR

PTB

139

Spoligotyping

130

71.54

84.62

SIT149, SIT53

EA, EAI

Diriba et al., 2013 [32]

AA

MDR-TB

184

Spoligotyping

184

85.87

77.72

SIT21, SIT149

EA and IO

Firdessa et al., 2013 [17]

AA, AM, OR, SNNPR

PTB, ETB

950

Spoligotyping, MIRU-VNTR, SNP

950

62.21

81.79

SIT149, SIT25

EA, EAI

Garedew et al., 2013a [33]

AM

PTB

71

Spoligotyping

96

85.42

94.79

SIT149, SIT53

EA

Garedew et al., 2013b [34]

AM

ETB

44

Spoligotyping

44

79.54

95.45

SIT54, SIT53

EA, IO

Workalemahu et al., 2013 [36]

OR

Child TB

15

Spoligotyping

24

54.17

54.17

SIT37

EA

Yimer et al., 2013 [37]

AM

PTB

237

Spoligotyping and MIRU-VNTR

237

83.54

82.70

SIT25, SIT910

CAS_DELHI

Belay et al., 2014 [38]

AM

PTB

105

Spoligotyping

103

77.67

93.20

SIT149, SIT37

T3-ETH, T3

Debebe et al., 2014 [39]

AM

PTB

118

Spoligotyping

118

83.89

89.83

SIT25 and SIT53

EA, CAS

Disassa et al., 2015 [42]

BG

PTB

33

Spoligotyping

33

45.45

75.76

SIT53

EA

Gebrezgabiher et al., 2015 [43]

SNNPR

PTB, ETB

31

Spoligotyping

31

38.71

61.29

SIT53

EA

Getahun et al., 2015 [44]

ETH

PTB

92

Spoligotyping

91

70.33

58.24

SIT53, SIT149

EA, EAI

Korma et al., 2015 [45]

AA

ETB

58

Spoligotyping

58

60.34

82.76

SIT53, SIT149

T

Maru et al., 2015 [46]

AM

PTB

118

Spoligotyping

118

73.73

90.68

SIT25, SIT53

H, T, CAS-DELHI

Nuru et al., 2015 [47]

AM

PTB, ETB

168

Spoligotyping

168

58.33

72.62

SIT289, SIT134

EA, EAI

Zewudie et al., 2016 [51]

AA

PTB, ETB

73

Spoligotyping

73

61.64

79.45

SIT149, SIT53

T, CASI-DELHI

Nuru et al., 2017 [52]

AM

PTB, ETB

38

Spoligotyping

38

36.84

68.42

SIT53, SIT289

EA, EAI

Bedawi et al., 2017 [54]

OR & SNNPR

PTB

281

Spoligotyping

281

79.36

79.72

SIT53, SIT149

EA

aAA Addis Ababa, AM Amhara, AF Afar, BG BenishangulGumz, DD Dire Dawa, GM Gambella, HR Harari, OR Oromia, SNNPR South Nation and Nationalities Peoples Region, SM Ethiopian Somali, TG Tigray. bPTB Pulmonary Tuberculosis, ETB Extra-pulmonary TB. cRFLP Restriction fragment length polymorphism, MIRU-VNTRs Mycobacterial interspersed repetitive units-variable tandem repeats of DNA tandem repeats. d The spoligo international type (SIT) numbers designate spoligotypes shared by two or more patient isolates

Fig. 2

Proportions of shared strains of M. tuberculosis reported from Ethiopia

Fig. 3

Distribution of M. tuberculosis lineages using spoligotyping across regions of Ethiopia. The lineages identified were: Lineage 1 (L-1) or Indo-Oceanic (IO), L-2 or East Asian (EA), L-3 or East African India (EAI) and L-4 or Euro-American (EUA), L-7 or Ethiopian and Unknown (U). The predominant lineages identified from almost all regions of the country were L-4. The Ethiopian L-7 was mainly identified from Amhara region and there was no data from Gambella region and very few strains (four) belongs to L-3 from Tigray region and one strain each belongs to L-4 from Dire Dawa city and Harari region. AA: Addis Ababa, AM: Amhara, AF: Afar, BG: Benishangul-Gumz, DD: Dire Dawa, HR: Harari, OR: Oromia, SNNPR: South Nation and Nationalities Peoples’, SM: Somali and TG: Tigray. Proportions of total lineages identified in Ethiopia namely; L-1 (7.1%), L-2 (0.2%), L-3 (23.0%), L-4 (64.8%) and L-7 (4.1%)

According to the spoligotyping analysis, the identified shared types of M. tuberculosis were classified into four major lineages namely L-1 or Indo-Oceanic, L-2 or East Asian, L-3 or East African India, L-4 or Euro-America and L-7 or Ethiopian (Fig. 3 and Table 2).
Table 2

Distribution of lineages/sublineages of the shared cluster containing 3 or more isolates from Ethiopia (n = 2584) based on spoligotyping data

Lineage

Clade/Sublineagea

Total strains

Percentage

Lineage 1 (Indo-Oceanic)

EAI

22

0.9

 

EAI1-SOM

5

0.2

 

EAI5 or EAI3

4

0.15

 

EAI6-BGD1

4

0.15

 

F33

9

0.35

 

MANU

156

6.0

 

Manu_ancestor

41

1.6

 

MANU2

115

4.5

Lineage 2 (East Asian)

Beijing

5

0.2

Lineage 3 (East African-Indian)

CAS

598

23.1

 

CAS

21

0.8

 

CAS_DELHI

472

18.3

 

CAS1_KILI

105

4.0

Lineage 4 (Euro-American)

Haarlem

281

10.1

 

H1

24

0.9

 

H3

188

7.3

 

H4

58

2.2

 

H4/Ural-1

11

0.4

 

LAM

101

3.9

 

LAM1

4

0.15

 

LAM10

4

0.15

 

LAM3 and S/Convergent

24

0.9

 

LAM5

6

0.2

 

LAM7_TUR

44

1.7

 

LAM9

19

0.7

 

S

3

0.12

 

T

1247

48.3

 

T

10

0.4

 

T1

502

19.4

 

T1 (Tuscany variant)

3

0.12

 

T1/T3

5

0.2

 

T2

85

3.3

 

T2-T3

5

0.2

 

T3

191

7.4

 

T3-ETH

434

16.8

 

T4

12

0.5

 

X

45

1.8

 

X1

40

1.6

 

X2

5

0.2

Lineage 7 (Ethiopian)

Ethiopian

107

4.1

Unknown

Unknown

19

0.7

 

U

8

0.31

 

U (likely H)

8

0.31

 

U (likely T3)

3

0.12

aClade designations according to STVIT2 and TBinsight database: Beijing clade, East African-Indian (EAI) clade and its sub-lineages, Haarlem (H) clade and its sub-lineages, Latin American-Mediterranean (LAM) clade and its sub-lineages, the ancestral “Manu” family and 3 sub-lineages, the IS6110-low-binding X clade and its sub-lineage, and an ill-defined T clade with its sub-lineages, U: Unknown patterns

The majority (64.8%) of the isolates belongs to the L-4 followed by L-3 (23.0%), L-1 (7.1%) and L-7 (4.1%). The prevalence of L-2 was the lowest (0.2%) as compared to the other lineages reported (Fig. 3). Concerning the newly investigated Ethiopian lineage, although it was reported from Addis Ababa city administration, Oromia region and SNNPR, it was predominantly reported Amhara region (77%).

The most predominant clades identified to date include the T clade, the Central-Asian (CAS) clade, Haarlem (H) clade, Manu clade, recently investigated Ethiopian clade (Lineage 7) and Latin American-Mediterranean (LAM) clade which makes up about 96% of the reported clades so far. The T and CAS genotype shared the major clades in almost all part of the country except no information from Gambella region (Fig. 4).
Fig. 4

Distribution of clades of M. tuberculosis identified in different regions of Ethiopia. Clade designations according to STVIT2 and TBinsight database: Beijing clade in East Asian lineage; CAS clade in East African-Indian (EAI) lineage; Haarlem (H) clade, Latin American-Mediterranean (LAM) clade, the ancestral “Manu” family, an ill-defined T clade and the IS6110-low-binding X clade in Euro American; ETH belongs to the newly identified Ethiopian lineage 7

The predominant associated sub-lineages identified include T1, T3-ETH, CAS-Delhi, H3, Manu2, and LAM-TUR. More specifically, the most predominant shared types were SIT149 (T3-ETH, n = 420, 16.2%), SIT53 (T1, n = 343, 13.2%), SIT25 (CAS1-Delhi, n = 266, 10.2%), SIT37 (T3, n = 162, 6.2%), SIT21 (CAS-Kili, n = 102, 4.0%), SIT26 (CAS-Delhi, n = 76, 3.0%), SIT54 (MANU2, n = 87, 3.4%), SIT52 (T2, n = 69, 2.7%), SIT910 (New Ethiopian, n = 65, 2.5%) and SIT289 (CAS-Delhi, n = 59, 2.3%) (Table 2 and Additional file 1).

In Table 3 above, a comparison of dominant isolates (> 2.0%) between our study and those previously reported in the SITVIT2 database from Ethiopia, neighboring countries in the regions and sub-regions was made. The result showed that the SIT53 (T1) and SIT26 (CAS-Delhi) were the most widely distributed isolates the regions. On the other hand, SIT910 (ETH) and 289 (CAS1-Delhi) have limited distribution in the African region (Table 3).
Table 3

Description of clusters containing greater than 2% of isolates in this study and their worldwide distribution in the SITVIT2 database

SIT (Clade)

Octal number

N. strains (%) in this study

N. in the data base

Distribution in regions with ≥3% of a given SITsa

Distribution in countries with ≥3% of a given SITsb

149 (T3_ETH)

777,000,377,760,771

420 (16.2)

241

EURO-N 33.2, AFRI-E 32.4, EURO-W 12.4, ASIA-W 10.8, AMER-N 8.7

ETH 32.4, DNK 23.6, SAU 10.8, USA 8.7, NLD 7.1, GBR 5.8, FRA 3.7

53 (T1)

777,777,777,760,771

343 (13.2)

3812

AMER-N 21.7, EURO-W 16.1, AMER-S 9.8, EURO-S 9.2, ASIA-W 8.3, AFRI-S 6.3, EURO-N 5.5, AFRI-E 3.9

USA 21.3, ZAF 6.1, ITA 5.9, AUT 5.6, BRA 5.1, TUR 4.3, FRA 3.9, SAU 3.4

25 (CAS_DELHI)

703,777,740,003,171

266 (10.2)

254

ASIA-W 34.3, ASIA-S 11.8, EURO-N 6.3, AFRI-N 9.8, EURO-W 9.1, AMER-N 19.3

SAU 33.8, USA 19.3, IND 6.3, SDN 5.5, NLD 5.5, GBR 3.9, LIB 3.5

37 (T3)

777,737,777,760,771

162 (6.2)

243

EURO-W 18.9, AMER-N 17.3, ASIA-W 13.6, EURO-N 12.8,EURO-E 7, ASIA-S 6.2, EURO-S 4.5, AMER-S 4.1,AFRI-E 3.7, CARI 3.7

USA 15.2, SAU 9.8, DNK 7.0, NLD 5.7, AUT 4.9, CZE 4.9, IND 4.5, BGR 3.9, ITA 3.7, FRA 3.3, TUR 3.3

21 (CAS1_KILI)

703,377,400,001,771

102 (4.0)

243

AFRI-E 61.3, AMER-N 9.1, EURO-W 8.6, EURO-N 7, AFRI-S 5.3, ASIA-W 4.9

TZA 25.5, MDG 15.2, USA 9.0, ZMB 9.0, KEN 7.0, NLD 5.3, ZAF 5.3, SAU 4.9, GBR 4.1

54(MANU2)

777,777,777,763,771

87 (3.4)

114

ASIA-S 21.1, AMER-N 17.5, AFRI-S 14, ASIA-W 12.3, ASIA-N 8.8, AMER-S 3.5, EURO-N 3.5, EURO-W 3.5

IND 19.3, USA 17.5, ZAF 14.0, SAU 9.6, RUS 8.8

26(CAS1_DELHI)

703,777,740,003,771

76 (3.0)

896

ASIA-S 48.4, AMER-N 23.7, EURO-N 8.6, ASIA-W 7.9, EURO-N 3

USA 23.7, IND 23.4, PAK 16.1, BGD 8.0, SAU 7.8, NLD 4.8

52 (T2)

777,777,777,760,731

69 (2.7)

526

EURO-W 26, AMER-N 19.8, EURO-E 7.6, EURO-N 6.5, AFRI-M 6.3, ASIA-W 5.7, EURO-S 5.5, AFRI-S 3.8, AFRI-S 3.8, AFRI-E 3.2

USA 19.0, BLG 8.4, FRA 7.6, NLD 5.1, AUS 4.4, CZE 4.7, ITA 4.7, CAM 4.5, ZAF 3.8

910 (ETH)

700,000,007,177,771

65 (2.5)

5

AMER-N 60, AFRI-E 40

USA 60.0, ETH 40.0

289(CAS1_DELHI)

703,777,740,003,571

59 (2.3)

9

ASIA-S 44.4, EURO-W 22.2, ASIA-W 11.1, AUST 11.1, AMER-N 11.1

NZD 22.2, PAK 22.2, AUS 11.1, BGD 11.1, IND 11.1, SAU 11.1, USA 11.1

aWorldwide distribution of SITs with more than 3% in the SITVIT2 until April 2, 2017, were included. Regions and sub-regions are defined according to United Nations (http://unstats.un.org/unsd/methods/m49/m49regin.htm); regions: AFRI (Africa), AMER(Americas), ASIA(Asia), EURO(Europe), and OCE (Oceania), subdivided in: E (Eastern),M(Middle), C (Central), N (Northern), S (Southern), SE (South-Eastern), and W(Western). Furthermore, CARIB (Caribbean) belongs to Americas, while Oceania is subdivided in 4subregions, AUST (Australasia), MEL (Melanesia), MIC (Micronesia), and POLY (Polynesia).bThe 3-letter country codes are according to http://en.wikipedia.org/wiki/ISO 3166–1 alpha-3; countrywide distribution is only shown for SITs with ≥3% of given SITs as compared to their totalnumberintheSITVIT2 database

Discussion

M. tuberculosis genotypes reported from Ethiopia to date primarily belonged to the four major lineages namely; L-1 associated with populations living around the Indian Ocean, L-3 associated with populations from Central Asia also common in East Africa, L-4 associated with a widespread Euro-American lineage [41] and more recently a new L-7 belonged to Ethiopian people has been identified [17]. The investigation of the new L-7 has strongly supported the existence of TB in the area or in the continent long before the European colonial contact. Moreover, the existence of TB in the area also contributed to the rejection of the “virgin soil” hypothesis of TB in Sub-Saharan Africa. According to “virgin soil” hypothesis TB epidemic in the African region was due to European contact during the colonial period as it was originally free of TB [41].

In this review, only very few studies were found on RFLP-IS6110 [25, 26], MIRU-VNTR [35, 40, 48, 49] and genome sequencing [17, 41, 50]. As a result, the evidence generated is acceptable enough for spoligotyping. Moreover, from the reported strains so far in the country, very few strains (< 5%) were from Benishangul-Gumz region, Harari region, Tigray region and from pastoral communities of Ethiopian Somali, Oromia, and SNNPR regions. This might also compromise the complete understanding of the strain diversity and transmission dynamics of M. tuberculosis in Ethiopia. These regions are also known by active trans-country movements and source of refugees that could play its role in the dynamicity of TB transmission in the country. Thus, this highlights a further systematic investigation of the epidemiology of M. tuberculosis in the regions. Nevertheless, from the spoligotyping result, it is possible to understand that Ethiopia is a home for a complex genetic diversity of TB ranging from ancient to new or modern TB lineages.

The presence of high clustering rates for spoligotypes suggests that a high transmission rate of M. tuberculosis clone exists in the country. However, a study supported by Geographic Information System (GIS) mapping of cluster position of a strain reported that majority of the cluster strains are far apart [44]. Thus, GIS mapping supported cluster position studies are recommended in order to have a clear understanding of the ongoing M. tuberculosis transmission dynamics. The detection of a high number of previously unreported strains in the TB global databases requires further genotyping analysis to be conducted in Ethiopia.

Even though its prevalence is very low, the STI1 genotype which belongs to the Beijing genotype of East-Asian lineage has been reported from major regions of the country including Amhara, Oromia, and SNNPR and from the capital Addis Ababa. Besides its worldwide distribution, the Beijing strains have been linked to an increased virulence, drug resistance and ability to spread. Thus, it is important to monitor the distribution through continues surveillance and reporting.

Strength and limitations

This review has explored all published articles on the genotype of M. tuberculosis identified from Ethiopian population without time and language limitation. As a result, the finding has generated a good picture of the distribution of lineages and strains across the country. However, in some regions only very few strains were reported and we found it difficult to generalize. The scope of this review also primarily focuses on the spoligotyping results of the studies and hence, its applicability is limited to spoligotyping method.

Conclusion

This is the first systematic review of genetic diversity of M. tuberculosis strains from Ethiopia. The lack of genotyping information available for clinical isolates of M. tuberculosis from the developing regions (Benishangul-Gumz, Gambella, Afar, Ethiopian Somali) and pastoral areas of the country specifically using MIRU-VNTR genotyping and or genome sequencing requires due attention for further analysis. The detection of the high number of spoligotypes previously in the global database highlights the need for additional analysis to be conducted in Ethiopia. Most importantly, further information regarding the risk of clustering of strains using GIS supported information and the status of Beijing strains in Ethiopia needs to be monitored. Some strains are also known to be associated with drug resistance and this also requires attention in future analysis. Furthermore, additional studies are needed to evaluate the transmission dynamics and drug-resistant TB in the country.

Notes

Acknowledgements

We would like to thank our colleagues Dr. Delessa Damena, Dr. Temesgen Mohammed, Mr. Aboma Zewudie and Mr. Adane Worku for their technical support during the use of Spoligo databases.

Funding

None

Availability of data and materials

All data generated or analysed during this study are included in this published article [and its supplementary information file].

Authors’ contributions

BT conducted designing the study, literature search, reviewed literature, extracted data from the literature and prepared a draft of the manuscript. GA conceived the study, participated in the designing of the study and in the preparation of the draft of the manuscript, and critically reviewing the manuscript. Both authors read and approved the final manuscript.

Authors’ information

Begna Tulu is a Ph.D. student in Tropical and Infectious Diseases at Aklilu Lemma Institute of Pathobiology, Addis Ababa University. Bahir Dar University is his home institution. Gobena Ameni is a Professor of Molecular Microbiology at Aklilu Lemma Institute of Pathobiology, Addis Ababa University and working on Systems Biology of both human and animal tuberculosis in Ethiopia.

Ethics approval and consent to participate

Not applicable

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary material

12879_2018_3046_MOESM1_ESM.docx (59 kb)
Additional file 1: Description of M. tuberculosis shared types reported for TB strains isolated in Ethiopia from nine regional states and two city administrations (n = 2596). a In the SITVIT2 database, the spoligo international type (SIT) numbers designate spoligotypes shared by two or more patient isolates. In contrast, “orphan” designates patterns reported for a single isolate. b Clade designations according to STVIT2 database: Beijing clade, East African-Indian (EAI) clade and 9 sub-lineages, Haarlem (H) clade and 3 sub-lineages, Latin American-Mediterranean (LAM) clade and 12 sub-lineages, the ancestral “Manu” family and 3 sub-lineages, the S clade, the IS6110-low-binding X clade and 3 sub-lineages, and an ill-defined T clade with 5 sub-lineages, U: Unknown patterns, ** Belongs to new Ethiopian L7. c AA: Addis Ababa; AM: Amhara; AF: Afar; BG: Benishangul Gumz; DD: Dire Dawa; GM: Gambela; HR: Harari; OR: Oromia; SNNPR: South Nation and Nationalities Peoples Region; SM: Ethiopian Somali; TG: Tigray dHigh clustering rate reported. (DOCX 58 kb)

References

  1. 1.
    Feruglio SL, Tonby K, Kvale D, Dyrhol-Riise AM. Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection. Clin Exp Immunol. 2014;179:454–65.CrossRefGoogle Scholar
  2. 2.
    WHO: Global Tuberculosis Report 2015. France World Health Organization; 2015.Google Scholar
  3. 3.
    Organization WH: Global tuberculosis report 2016. 2016.Google Scholar
  4. 4.
    Ahmad S, Mokaddas E. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Respir Med. 2009;103(12):1777–90.CrossRefPubMedGoogle Scholar
  5. 5.
    Institute EPH. First National population-based tuberculosis prevalence survey. Addis Ababa, Ethiopia: Ethiopia Health Nutrition and Research Institute, Federal Democratic Republic of Ethiopia; 2011.Google Scholar
  6. 6.
    Dorman S. Advances in the diagnosis of tuberculosis: current status and future prospects. Int J Tuberc Lung Dis. 2015;19(5):504–16.CrossRefPubMedGoogle Scholar
  7. 7.
    Beresford B, Sadoff JC. Update on Research and Development pipeline: tuberculosis vaccines. Clin Infect Dis. 2010;50(3):S178–83.CrossRefPubMedGoogle Scholar
  8. 8.
    Gagneux S. Genetic diversity in Mycobacterium tuberculosis. Curr Top Microbiol Immunol. 2013;Google Scholar
  9. 9.
    Galagan JE. Genomic insights into tuberculosis. Nat Rev Genet. 2014;15(5):307–20.CrossRefPubMedGoogle Scholar
  10. 10.
    Guirado E, Schlesinger LS, Kaplan G. Macrophages in tuberculosis: friend or foe. Semin Immunopahol. 2013;35(5):563–83.CrossRefGoogle Scholar
  11. 11.
    Hu Y, Wu L, Li D, Zhao Q, Jiang W, Xu B. Association between cytokine gene polymorphisms and tuberculosis in a Chinese population in shanghai: a case-control study. BMC Immunol. 2015;16:8.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Lipner EM, Garcia BJ, Strong M. Network analysis of human genes influencing susceptibility to mycobacterial infections. Plos One. 2016;11(1):e0146585.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Zembrzuski VM, Basta PC, Callegari-Jacques SM, Santos RV, Coimbra CE, Salzano FM, Hutz MH. Cytokine genes are associated with tuberculin skin test response in a native Brazilian population. Tuberculosis (Edinb). 2010;90(1):44–9.CrossRefGoogle Scholar
  14. 14.
    Flores-Villalva S, Rogriguez-Hernandez E, Rubio-Venegas Y, Canto-Alarcon JG, Milian-Suazo F. What can proteomics tell us about tuberculosis? J Microbiol Biotechnol. 2015;25(8):1181–94.CrossRefPubMedGoogle Scholar
  15. 15.
    Delogu G, Sali M, Fadda G. The biology of mycobacterium tuberculosis infection. Mediterr J Hematol Infect Dis. 2013;5(1):e2013070.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393(6685):537–44.CrossRefPubMedGoogle Scholar
  17. 17.
    Firdessa R, Berg S, Hailu E, Schelling E, Gumi B, Erenso G, Gadisa E, Kiros T, Habtamu M, Hussein J, et al. Mycobacterial lineages causing pulmonary and extrapulmonary tuberculosis, Ethiopia. Emerg Infect Dis. 2013;19(3):460–3.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Gagneux S. Genetic diversity in Mycobacterium tuberculosis. Curr Top Microbiol Immunol. 2013;374:1–25.PubMedGoogle Scholar
  19. 19.
    Chang JR, Lin CH, Tsai SF, Su IJ, Tseng FC, Chen YT, Chiueh TS, Sun JR, Huang TS, Chen YS, et al. Genotypic analysis of genes associated with transmission and drug resistance in the Beijing lineage of Mycobacterium tuberculosis. Clin Microbiol Infect. 2011;17(9):1391–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Parwati I, van Crevel R, van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis. 2010;10(2):103–11.CrossRefPubMedGoogle Scholar
  21. 21.
    van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31(2):406–9.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006;44(12):4498–510.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35(4):907–14.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Kato-Maeda M, Metcalfe JZ, Flores L. Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies. Future Microbiol. 2011;6(2):203–16.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Hermans PW, Messadi F, Guebrexabher H, van Soolingen D, de Haas PE, Heersma H, de Neeling H, Ayoub A, Portaels F, Frommel D, et al. Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and the Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J Infect Dis. 1995;171(6):1504–13.CrossRefPubMedGoogle Scholar
  26. 26.
    Bruchfeld J, Aderaye G, Palme IB, Bjorvatn B, Ghebremichael S, Hoffner S, Lindquist L. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J Clin Microbiol. 2002;40(5):1636–43.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Beyene D, Bergval I, Hailu E, Ashenafi S, Yamuah L, Aseffa A, Wiker HG, Engers H, Klatser P, Sviland L. Identification and genotyping of the etiological agent of tuberculous lymphadenitis in Ethiopia. J Infect Dev Ctries. 2009;3(6):412–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Agonafir M, Lemma E, Wolde-Meskel D, Goshu S, Santhanam A, Girmachew F, Demissie D, Getahun M, Gebeyehu M, van Soolingen D. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia. Int J Tuberc Lung Dis. 2010;14(10):1259–65.PubMedGoogle Scholar
  29. 29.
    Deribew A, Abebe G, Apers L, Abdissa A, Deribe F, Woldemichael K, Jira C, Tesfaye M, Shiffa J, Aseffa A, et al. Prevalence of pulmonary TB and spoligotype pattern of Mycobacterium tuberculosis among TB suspects in a rural community in Southwest Ethiopia. BMC Infect Dis. 2012;12:54.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Mihret A, Bekele Y, Loxton AG, Jordan AM, Yamuah L, Aseffa A, Howe R, Walzl G. Diversity of Mycobacterium tuberculosis isolates from new pulmonary tuberculosis cases in Addis Ababa, Ethiopia. Tuberc Res Treat. 2012;2012:892079.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Ameni G, Tadesse K, Hailu E, Deresse Y, Medhin G, Aseffa A, Hewinson G, Vordermeier M, Berg S. Transmission of Mycobacterium tuberculosis between farmers and cattle in Central Ethiopia. PLoS One. 2013;8(10):e76891.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Diriba B, Berkessa T, Mamo G, Tedla Y, Ameni G. Spoligotyping of multidrug-resistant Mycobacterium tuberculosis isolates in Ethiopia. Int J Tuberc Lung Dis. 2013;17(2):246–50.CrossRefPubMedGoogle Scholar
  33. 33.
    Garedew L, Mihret A, Ameni G. Molecular typing of mycobacteria isolated from extrapulmonary tuberculosis patients at Debre Birhan referral hospital, Central Ethiopia. Scand J Infect Dis. 2013;45(7):512–8.CrossRefPubMedGoogle Scholar
  34. 34.
    Garedew L, Mihret A, Mamo G, Abebe T, Firdessa R, Bekele Y, Ameni G. Strain diversity of mycobacteria isolated from pulmonary tuberculosis patients at Debre Birhan hospital, Ethiopia. Int J Tuberc Lung Dis. 2013;17(8):1076–81.CrossRefPubMedGoogle Scholar
  35. 35.
    Tessema B, Beer J, Merker M, Emmrich F, Sack U, Rodloff AC, Niemann S. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in Northwest Ethiopia: new phylogenetic lineages found in Northwest Ethiopia. BMC Infect Dis. 2013;13:131.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Workalemahu B, Berg S, Tsegaye W, Abdissa A, Girma T, Abebe M, Aseffa A. Genotype diversity of Mycobacterium isolates from children in Jimma, Ethiopia. BMC Res Notes. 2013;6:352.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Yimer SA, Hailu E, Derese Y, Bjune GA, Holm-Hansen C. Spoligotyping of Mycobacterium tuberculosis isolates among pulmonary tuberculosis patients in Amhara region, Ethiopia. APMIS. 2013;121(9):878–85.CrossRefPubMedGoogle Scholar
  38. 38.
    Belay M, Ameni G, Bjune G, Couvin D, Rastogi N, Abebe F. Strain diversity of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in afar pastoral region of Ethiopia. Biomed Res Int. 2014;2014:238532.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Debebe T, Admassu A, Mamo G, Ameni G. Molecular characterization of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients in Felege Hiwot referral hospital, Northwest Ethiopia. J Microbiol Immunol Infect. 2014;47(4):333–8.CrossRefPubMedGoogle Scholar
  40. 40.
    Biadglegne F, Merker M, Sack U, Rodloff AC, Niemann S. Tuberculous lymphadenitis in Ethiopia predominantly caused by strains belonging to the Delhi/CAS lineage and newly identified Ethiopian clades of the Mycobacterium tuberculosis complex. PLoS One. 2015;10(9):e0137865.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Comas I, Hailu E, Kiros T, Bekele S, Mekonnen W, Gumi B, Tschopp R, Ameni G, Hewinson RG, Robertson BD, et al. Population genomics of Mycobacterium tuberculosis in Ethiopia contradicts the virgin soil hypothesis for human tuberculosis in Sub-Saharan Africa. Curr Biol. 2015;25(24):3260–6.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Disassa H, Tafess K, Worku A, Ameni G. A preliminary study on molecular characterization of Mycobacterium tuberculosis in Benishangul Gumuz region, Western Ethiopia. Br Microbiol Res J. 2015;10(6):1–10.CrossRefGoogle Scholar
  43. 43.
    Gebrezgabiher G, Romha G, Ameni G. Spoligotyping of Mycobacterium tuberculosis isolates from tuberculosis diagnosed patients at Dilla University referral hospital and other private clinics, Southern Ethiopia. Asian Pac J Trop Dis. 2015;5(4):329–33.CrossRefGoogle Scholar
  44. 44.
    Getahun M, Ameni G, Kebede A, Yaregal Z, Hailu E, Medihn G, Demssie D, Girmachew F, Fiseha Y, Meaza A, et al. Molecular typing and drug sensitivity testing of Mycobacterium tuberculosis isolated by a community-based survey in Ethiopia. BMC Public Health. 2015;15:751.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Korma W, Mihret A, Hussien J, Anthony R, Lakew M, Aseffa A. Clinical, molecular and drug sensitivity pattern of mycobacterial isolates from extra-pulmonary tuberculosis cases in Addis Ababa, Ethiopia. BMC Infect Dis. 2015;15:456.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Maru M, Mariam SH, Airgecho T, Gadissa E, Aseffa A. Prevalence of tuberculosis, drug susceptibility testing, and genotyping of mycobacterial isolates from pulmonary tuberculosis patients in Dessie, Ethiopia. Tuberc Res Treat. 2015;2015:215015.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Nuru A, Mamo G, Worku A, Admasu A, Medhin G, Pieper R, Ameni G. Genetic diversity of Mycobacterium tuberculosis complex isolated from tuberculosis patients in Bahir Dar City and its surroundings, Northwest Ethiopia. Biomed Res Int. 2015;2015:174732.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Yimer SA, Norheim G, Namouchi A, Zegeye ED, Kinander W, Tonjum T, Bekele S, Mannsaker T, Bjune G, Aseffa A, et al. Mycobacterium tuberculosis lineage 7 strains are associated with prolonged patient delay in seeking treatment for pulmonary tuberculosis in Amhara region, Ethiopia. J Clin Microbiol. 2015;53(4):1301–9.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Ali S, Beckert P, Haileamlak A, Wieser A, Pritsch M, Heinrich N, Loscher T, Hoelscher M, Niemann S, Rachow A. Drug resistance and population structure of M. Tuberculosis isolates from prisons and communities in Ethiopia. BMC Infect Dis. 2016;16(1):687.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Yimer SA, Namouchi A, Zegeye ED, Holm-Hansen C, Norheim G, Abebe M, Aseffa A, Tonjum T. Deciphering the recent phylogenetic expansion of the originally deeply rooted Mycobacterium tuberculosis lineage 7. BMC Evol Biol. 2016;16(1):146.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Zewdie O, Mihret A, Ameni G, Worku A, Gemechu T, Abebe T. Molecular typing of mycobacteria isolated from tuberculous lymphadenitis cases in Addis Ababa, Ethiopia. Int J Tuberc Lung Dis. 2016;20(11):1529–34.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Nuru A, Mamo G, Zewude A, Mulat Y, Yitayew G, Admasu A, Medhin G, Pieper R, Ameni G. Preliminary investigation of the transmission of tuberculosis between farmers and their cattle in smallholder farms in northwestern Ethiopia: a cross-sectional study. BMC Res Notes. 2017;10(1):31.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Bedewi Z, Worku A, Mekonnen Y, Yimer G, Medhin G, Mamo G, Pieper R, Ameni G. Molecular typing of Mycobacterium tuberculosis complex isolated from pulmonary tuberculosis patients in Central Ethiopia. BMC Infect Dis. 2017;17(1):184.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Author(s). 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  1. 1.Aklilu Lemma Institute of PathobiologyAddis Ababa UniversityAddis AbabaEthiopia
  2. 2.Department of Microbiology, Immunology and ParasitologyBahir Dar UniversityBahir DarEthiopia

Personalised recommendations